Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors

Wijma S, De Boer J
Record ID 32018001077
Dutch
Original Title: Package advice emicizumab (Hemlibra®)
Authors' objectives: Package advice emicizumab Hemlibra
Details
Project Status: Completed
Year Published: 2020
Requestor: National Health Care Institute
English language abstract: An English language summary is available
Publication Type: Other
Country: The Netherlands
MeSH Terms
  • Drug Therapy, Combination
  • Blood Coagulation Factors
  • Hemophilia A
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Bispecific
Keywords
  • emicizumab
  • Hemlibra
Contact
Organisation Name: The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address: Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name: Timon Sibma
Contact Email: TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.